Updated regularly

Skincare research, explained for everyone

SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language โ€” with evidence labels, source links, and no hype.

Today's insight

13 May

Acne's emotional toll goes beyond self-esteem. Research suggests emotional distress may contribute to the development and progression of skin diseases like acne. More study is needed to fully understand this complex link.

Acne & Emotional Distress Study

Browse by ingredient

View all

Browse by condition or concern

View all

Recent findings

View all
In VitroCell or tissue culture experiments. No human or animal data.TretinoinPublished: May 12, 2026

Niosomal Cream May Help Improve Tretinoin Stability and Efficacy

Researchers developed a new cream that encapsulates tretinoin, a common skincare ingredient, in tiny particles called niosomes. They tested this cream in lab experiments and found that it may improve tretinoin's stability and effectiveness. However, more research is needed to confirm these results.

Why it matters: This study may help improve our understanding of how to deliver tretinoin more effectively in skincare products.

Lab experiments only, more in vivo and clinical research is needed to validate these results.

PubMedโ†—
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: May 11, 2026

New Acne Treatment May Help Reduce Pore Size

Researchers studied a new acne treatment that uses gold nanoparticles and a laser to target acne. A small study found that this treatment may help reduce pore size and improve acne symptoms. The treatment was tested on three adolescent patients with mild acne. The study used ultrasound to monitor the treatment's effectiveness.

Why it matters: This study may help skincare professionals understand how to monitor the effectiveness of new acne treatments.

This study had a small sample size of only three patients and was a short-term study.

PubMedโ†—
โ—† Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Skin Barrier DamagePublished: May 11, 2026

Indocyanine Green Fluorescence for Melanoma Sentinel Lymph Node Detection

Researchers studied how well indocyanine green fluorescence compares to conventional techniques for detecting sentinel lymph nodes in melanoma patients. They found that indocyanine green fluorescence can be effective, but its performance varies depending on the situation. More research is needed to fully understand its benefits and limitations.

Why it matters: This research may help improve the accuracy of melanoma staging and treatment planning.

The study synthesizes data from various sources, including prospective series, head-to-head studies, and systematic reviews/meta-analyses, but does not present new primary data.

PubMedโ†—
Animal StudyResults in animals only. May or may not translate to humans.Skin Barrier DamagePublished: May 10, 2026

Alectinib's Skin and Liver Side Effects May Be Linked

Researchers studied the medication alectinib, used to treat lung cancer, and found that its side effects on the skin and liver may be connected. They discovered that alectinib can cause the liver to break down a protein called biotinidase, leading to a deficiency that affects both the liver and skin. This may explain why some people taking alectinib experience skin problems and liver damage.

Why it matters: Understanding the link between alectinib's side effects may help doctors find ways to minimize these problems for patients.

This study was conducted in lab experiments and animal models, and its findings may not directly apply to humans. Further research is needed to confirm these results.

PubMedโ†—
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: May 9, 2026

New In-Vehicle System May Help Identify Dangerous Driving Behaviors

Researchers developed a system to identify dangerous driving behaviors using 3D vision. The system uses a Time-of-Flight camera to estimate the 3D poses of drivers and recognize hazardous behaviors. It achieved high accuracy in lab experiments. The system's performance was tested on an automotive embedded platform.

Why it matters: This research may have implications for developing safer in-vehicle systems, which could indirectly benefit road safety and public health.

This study was conducted in a controlled environment and its results may not directly translate to real-world driving scenarios. The system's performance was tested on a specific automotive platform, which may not be representative of all vehicles.

PubMedโ†—
In VitroCell or tissue culture experiments. No human or animal data.Published: May 9, 2026

Low-Level Laser Therapy May Help Regulate Fibroblast Activity

Researchers studied how different settings of low-level laser therapy (LLLT) affect the behavior of fibroblasts, cells that play a key role in wound healing. They found that certain settings may help regulate fibroblast activity, but more research is needed to confirm these findings. The study was conducted in a lab setting using cell cultures.

Why it matters: Understanding how LLLT affects fibroblast activity may provide insights into its potential benefits for wound healing and skin regeneration.

This study was conducted in a lab setting using cell cultures, and its findings may not directly translate to human skin. Further research is needed to confirm these results and determine their relevance to human skin health.

PubMedโ†—

What is SkinCareRadar?

SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.

Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.

Read our methodology โ†’